Multiple endocrine neoplasia type 2A: An unusual clinical presentation and association with renal dysplasia

Cancer Genetics and Cytogenetics

Volumn 141, Issue 2, 2003, Pages 157-159

  McIntyre, Elizabeth ^a   Bond, Patricia ^b   Douglas, Fiona ^b   Lennard, Tom ^b   Peaston, Robert ^a   Perros, Petros ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADRENALECTOMY; ADULT; AMINO ACID SUBSTITUTION; ARTICLE; CANCER DIAGNOSIS; CASE REPORT; CLINICAL FEATURE; ECHOGRAPHY; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GOOD GENERAL CONDITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; KIDNEY DYSPLASIA; MALE; NEPHRECTOMY; PARATHYROIDECTOMY; PHEOCHROMOCYTOMA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SIPPLE SYNDROME; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADULT; DROSOPHILA PROTEINS; HUMANS; KIDNEY; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 0037372267     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(02)00663-5     Document Type: Article

References (14)

1. Mulligan L.M., Ponder B.A.J. Genetic basis of endocrine disease. J Clin Endocrinol Metab. 80:1995;1989-1994.
2. Eng C. Multiple endocrine neoplasia type 2 and the practice of molecular medicine. Rev Endocr Metab Disord. 1:2000;283-290.
3. Eng C., Clayton D., Schuffenecker I., Lenoir G., Cote G., Gagel R.F., van Amstel H.K., Lips C.J., Nishisho I., Takai S.I., Marsh D.J., Robinson B.G., Frank-Raue K., Raue F., Xue F., Noll W.W., Romei C., Pacini F., Fink M., Niederle B., Zedenius J., Nordenskjold M., Komminoth P., Hendy G.N., Mulligan L.M. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. international RET mutation consortium analysis JAMA. 276:1996;1575-1579.
4. Hansford J.R., Mulligan L.M. Multiple endocrine neoplasia type 2 and RET. from neoplasia to neurogenesis J Med Genet. 37:2000;817-827.
5. Panchis V., Mankoo M., Costantini F. Expression of the c-ret oncogene during mouse embryogenesis. Development. 119:1993;1005-1017.
6. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F., Panchnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 367:1994;380-383.
7. Borst M.J., VanCamp J.M., Peacock B.A., Decker R.A. Mutational analysis of multiple endocrine neoplasia type 2A associated with Hirschsprung's disease. Surgery. 117:1995;386-391.
8. Decker R.A., Peacock M.L. Occurrence of MEN 2a in familial Hirschsprung's disease. a new indication for genetic testing of the RET proto-oncogene J Pediatr Surg. 33:1998;207-214.
9. Lore F., Cairano G., Talidis F. Unilateral renal agenesis in a family with medullary thyroid carcinoma. N Engl J Med. 342:2000;1218-1219.
10. Lombardo F., Filetti S., Crocetti U., Schlumberger M. Medullary thyroid carcinoma and lack of renal agenesis. Thyroid. 11:2001;93.
11. Decker R.A., Peacock M.L., Watson P. Hirschsprung disease in MEN 2A. increased spectrum of RET exon 10 genotypes and strong genotype-phenotype correlation Hum Mol Genet. 7:1998;129-134.
12. Takahashi M., Iwashita T., Santoro M., Lyonnet S., Lenoir G.M., Billaud M. Co-segregation of MEN2 and Hirschsprung's disease. the same mutation of RET with both gain and loss-of-function? Hum Mutat. 13:1999;331-336.
13. Ito S., Iwashita T., Asai N., Murakami H., Iwata Y., Sobue G., Takahashi M. Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype. Cancer Res. 57:1997;2870-2872.
14. Borrego S., Eng C., Sanchez B., Saez M.E., Navarro E., Antinolo G. Molecular analysis of the ret and GDNF genes in a family with multiple endocrine neoplasia type 2A and Hirschsprung disease. J Clin Endocrinol Metab. 83:1998;3361-3364.